J D Neaton

发表

The design and conduct of clinical trials to limit missing data

R. Little, H. Stern, K. Dickersin, 2012, Statistics in medicine.

Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.

J. Neaton, R. Grimm, W. Ludwig, 1985, JAMA.

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

J. Neaton, J. Stamler, D. Wentworth, 1986, JAMA.

Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication

R J Prineas, R. Prineas, J. Neaton, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.

A. Dyer, P. Greenland, J. Neaton, 2000, JAMA.

Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J. Neaton, D. Wentworth, F. Rhame, 1994, Statistics in medicine.

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.

J P Matts, J. Neaton, D. Wentworth, 1994, The Journal of infectious diseases.

CD4+ count-guided interruption of antiretroviral treatment.

J Darbyshire, N Clumeck, J Hoy, 2006, The New England journal of medicine.

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

J. Neaton, J. Stamler, R. Stamler, 1993, Archives of internal medicine.

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

A. Dyer, P. Greenland, Kiang Liu, 1999, JAMA.

The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups.

J. Neaton, S. Broste, J. Schoenberger, 1981, Preventive medicine.

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

J. Neaton, D. Wentworth, J D Neaton, 1992, Archives of internal medicine.

Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: I. White men.

J. Neaton, J. Stamler, D. Wentworth, 1996, American journal of public health.

An examination of the efficiency of some quality assurance methods commonly employed in clinical trials.

A. G. Duchene, J. Neaton, D. Wentworth, 1990, Statistics in medicine.

Forms control and error detection procedures used at the Coordinating Center of the Multiple Risk Factor Intervention Trial (MRFIT).

P. Grambsch, J. Neaton, S. Broste, 1986, Controlled clinical trials.

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

S B Hulley, W. Kannel, J. Neaton, 1986, American heart journal.

Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men.

R J Prineas, D R Jacobs, R S Crow, 1987, The American journal of cardiology.

The relationship of white blood cell count to other cardiovascular risk factors.

J. Neaton, R. Grimm, J D Neaton, 1990, International journal of epidemiology.

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, N. Markowitz, R. Luskin-Hawk, 1994, The New England journal of medicine.